Snowball logo
logo
PZRX_logo

PhaseRx Inc

PZRXQ • PINK
$0.0001$0.00  (0%)
Estimate
EPS
-0.01
Beta
32.579
About the company
Ticker
PZRXQ
ISIN
US71723F1030
Country
United States of America
Sector (GICS)
Healthcare
PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. PhaseRx, Inc., was incorporated in 2006 and is headquartered in Seattle, Washington.

Frequently asked questions

What sector does PhaseRx Inc (PZRXQ) operate in?

PhaseRx Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is PhaseRx Inc (PZRXQ) current stock price?

As of the latest data, PhaseRx Inc stock price is $0.00, with a previous close of $0.00.

What is PhaseRx Inc (PZRXQ) current market capitalization?

PhaseRx Inc market cap is approximately 1.17 thousand.

What is PhaseRx Inc (PZRXQ) Earnings Per Share (EPS)?

The trailing EPS is -$0.01.

Does PhaseRx Inc (PZRXQ) pay dividends?

No. PhaseRx Inc does not pay a dividend.

What is PhaseRx Inc (PZRXQ) beta (volatility) score?

PhaseRx Inc has a beta of 32.579, indicating very high volatility compared to the market.